Cargando…
Blastic Plasmacytoid Dendritic Cell Neoplasm; A Report of Three Cases
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematodermic myeloid malignancy that is known to be derived from plasmacytoid dendritic cells which are characterized by expression of CD4, CD56, and more specific markers such as CD123. Here, the authors present three cases of BPDCN dia...
Autores principales: | Safaei, Akbar, Monabati, Ahmad, Mokhtari, Maral, Solhjoo, Freidoon, Montazer, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Journal of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330528/ https://www.ncbi.nlm.nih.gov/pubmed/30666080 |
Ejemplares similares
-
Evaluation of the CD123 Expression and FLT3 Gene Mutations in Patients with Acute Myeloid Leukemia
por: Safaei, Akbar, et al.
Publicado: (2018) -
Blastic plasmacytoid dendritic cell neoplasm
por: Lencastre, André, et al.
Publicado: (2013) -
Report on Three Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm
por: Bülbül, Hale, et al.
Publicado: (2018) -
Blastic plasmacytoid dendritic cell neoplasm
por: Rai, Manoj Ponadka, et al.
Publicado: (2018) -
Blastic Plasmacytoid Dendritic Cell Neoplasm: Case Report and Literature Overview
por: Kolerova, Anastasiia, et al.
Publicado: (2020)